Results 221 to 230 of about 128,641 (342)

The use of a single pulse of intravenous methylprednisolone in the treatment of corneal graft rejection. A preliminary report [PDF]

, 1991
John C. Hill, Richard Maske, Peter Watson   +2 more
openalex   +1 more source

Hyperprolactinemia as a manifestation of multiple sclerosis attack. [PDF]

BMJ Neurol Open
Golparvar S, Naghavi S, Adibi I.
europepmc   +1 more source

Effects of methylprednisolone on exercise‐induced increases of plasma levels of polymorphonuclear elastase and myeloperoxidase in man. Preliminary results [PDF]

, 1993
G. Camus, J. Pincemail, G. Deby‐Dupont, C. Deby, A. Juchmès-Ferir, Maurice Lamy   +5 more
openalex   +1 more source

Treatment options for immune‐related adverse events associated with immune checkpoint inhibitors

British Journal of Pharmacology, EarlyView.
Abstract The immunotherapy revolution with the use of immune checkpoint inhibitors (ICIs) started with the clinical use of the first ICI, ipilimumab, in 2011. Since then, the field of ICI therapy has rapidly expanded — with the FDA approval of 10 different ICI drugs so far and their incorporation into the therapeutic regimens of a range of malignancies.
Yu Hua Chen, Tamás Kovács, Péter Ferdinandy, Zoltán V. Varga   +3 more
wiley   +1 more source

Advanced Thymoma Successfully Treated with Cisplatin, Doxorubicin, and Methylprednisolone Therapy as Induction Chemotherapy: Two Surgical Cases and a Review of the Literature. [PDF]

Surg Case Rep
Sato A, Matsui Y, Toyoda T, Sata Y, Inage T, Tanaka K, Morimoto J, Chiyo M, Suzuki H.   +8 more
europepmc   +1 more source

Methylprednisolone in patients undergoing cardiopulmonary bypass (SIRS): a randomised, double-blind, placebo-controlled trial

The Lancet, 2015
Richard P Whitlock, Richard P Whitlock, P. Devereaux, P. Devereaux, K. Teoh, A. Lamy, A. Lamy, J. Vincent, J. Pogue, D. Paparella, D. Sessler, G. Karthikeyan, J. Villar, Y. Zuo, Á. Avezum, M. Quantz, G. Tagarakis, P. Shah, S. Abbasi, Hong Zheng, S. Pettit, S. Chrolavicius, Salim Yusuf, Salim Yusuf   +23 more
semanticscholar   +1 more source

Effect of time to initiation and dose of methylprednisolone on outcome in multiple sclerosis‐related optic neuritis

Clinical and Experimental Neuroimmunology, EarlyView.
Abstract Objectives It is known that the benefit of intravenous methylprednisolone (IVMP) in multiple sclerosis‐related optic neuritis (MS‐ON) is limited to an accelerated recovery. We aimed to evaluate the impact of time from symptoms onset to IVMP initiation and of IVMP dose on visual recovery among people with MS‐ON.
Hadar Gilad, Josepha Horowitz, Sivan Bloch, Daniel Golan   +3 more
wiley   +1 more source

Langerhans Cell Histiocytosis Successfully Treated with Combination of Thalidomide and Corticosteroid. [PDF]

Eur J Case Rep Intern Med
Mulansari NA, Muthalib A, Kurniawan C.
europepmc   +1 more source

Prognostic analysis of steroid-induced osteonecrosis of the femoral head in children with immune kidney disease. [PDF]

Ann Med
Liu J, Su Y, Nan G.
europepmc   +1 more source

Reversal of Apparent Tolerance to Epidural Morphine by Epidural Methylprednisolone

, 1987
Gary S. Feldstein, Steven D. Waldman, Mark L. Allen   +2 more
openalex   +1 more source